ASCO 2024 | Biomarkers and Efficacy Analysis of Immunotherapy Combinations for Metastatic Prostate Cancer

ASCO 2024 | Biomarkers and Efficacy Analysis of Immunotherapy Combinations for Metastatic Prostate Cancer

The efficacy of endocrine therapy in advanced prostate cancer patients is poor, with most ultimately progressing to castration-resistant prostate cancer (CRPC). Although previous single-agent immunotherapies have shown limited success in prostate cancer, recent studies indicate that combination immunotherapies exhibit higher antitumor activity in patients with metastatic CRPC (mCRPC). At the recent ASCO Annual Meeting, a study analyzed the efficacy of different immunotherapy combinations for mCRPC patients and examined potential biomarkers.
Can COVID-19 Vaccination Help Long COVID Symptoms?

Can COVID-19 Vaccination Help Long COVID Symptoms?

A recent study in The Journal of Infection suggests that SARS-CoV-2 vaccination may accelerate symptom resolution in individuals with ongoing symptomatic COVID-19 (OSC) and post-COVID syndrome (PCS). Using data from the ZOE COVID Symptom Study app, researchers found that vaccinated individuals experienced greater improvement in symptoms like fatigue and brain fog compared to unvaccinated individuals.
New Breakthrough in SARS-CoV-2 Immunotherapy

New Breakthrough in SARS-CoV-2 Immunotherapy

A recent study published in Emerging Microbes & Infections introduces C10, a pan-SARS-CoV-2 monoclonal antibody (mAb) that offers a novel approach to combating COVID-19. Unlike traditional neutralizing antibodies, C10 targets infected lung epithelial cells and mediates their elimination via NK cell-driven antibody-dependent cellular cytotoxicity (ADCC).
China-Europe Collaboration Brings New Hope for Cholangiocarcinoma Treatment – An Exclusive Interview with Dr. Chiara Braconi

China-Europe Collaboration Brings New Hope for Cholangiocarcinoma Treatment – An Exclusive Interview with Dr. Chiara Braconi

From February 20 to 22, 2025, the European Association for the Study of the Liver (EASL) Liver Cancer Summit was held in Paris, France. The first day of the conference was dedicated to Cholangiocarcinoma (CCA). Dr. Chiara Braconi, a leading expert in cholangiocarcinoma treatment from the University of Glasgow, UK, delivered a keynote lecture and later sat down for an exclusive interview with our publication.
Insightful Analysis and Future Blueprint: Academician Binghe Xu Highlights COMB, Outlining the Development of Innovative Breast Cancer Drugs in China

Insightful Analysis and Future Blueprint: Academician Binghe Xu Highlights COMB, Outlining the Development of Innovative Breast Cancer Drugs in China

From August 2-4, 2024, the Seventh Tumor Precision Diagnosis and Treatment Conference and the Tenth Breast Cancer Individualized Treatment Conference (COMB), hosted by the China Cancer Foundation and the Beijing Breast Disease Prevention and Treatment Society, were grandly held in Beijing. The conference brought together the latest advancements in individualized precision treatment of breast cancer in China, providing a broad stage for promoting new concepts, developing new technologies, and creating new models in the breast cancer field. "Oncology Frontier" specially interviewed the chairman of the COMB conference, Academician Binghe Xu from the Cancer Hospital , Chinese Academy of Medical Sciences and Peking Union Medical College, to highlight the key points of COMB, outline the blueprint for the development of innovative breast cancer drugs in China, and guide the research directions for immunotherapy in breast cancer.
Celebrating World Breastfeeding Week!

Celebrating World Breastfeeding Week!

Celebrating World Breastfeeding Week! From August 1st to 7th, we honor and support the beautiful journey of breastfeeding. Let's join hands to promote the importance of breastfeeding for both mothers and babies. It's more than just nourishment—it's about bonding, health, and giving our little ones the best start in life